Biomarkers Market Revenue 2024 to 2034
Biomarkers Market Revenue 2024 to 2034
The biomarkers market is projected to rise from USD 82.3 Bn in 2024 to USD 318.75 Bn by 2034, at a 14.5% CAGR, supported by precision medicine, cancer detection, and growing adoption of predictive diagnostic tools.
Report ID: 10553
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 82.30 Bn
Forecast Year,
USD 318.75 Bn
CAGR, 2025 -
14.50%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Biomarkers Market Size Analysis
Biomarkers Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Safety | 18.11 | 20.86 | 24.04 | 27.70 | 31.92 | 36.77 | 42.36 | 48.80 | 56.21 | 64.75 | 74.58 |
| Efficacy | 29.63 | 33.70 | 38.34 | 43.62 | 49.61 | 56.43 | 64.19 | 73.01 | 83.05 | 94.45 | 107.43 |
| Validation | 11.52 | 13.21 | 15.14 | 17.36 | 19.90 | 22.82 | 26.16 | 29.99 | 34.38 | 39.41 | 45.18 |
| Prognostic/Diagnostic | 23.04 | 26.45 | 30.37 | 34.86 | 40.02 | 45.94 | 52.74 | 60.54 | 69.49 | 79.77 | 91.57 |
Biomarkers Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery/Development | 36.21 | 41.43 | 47.40 | 54.22 | 62.03 | 70.97 | 81.19 | 92.89 | 106.27 | 121.58 | 139.10 |
| Diagnostics | 26.34 | 30.04 | 34.26 | 39.07 | 44.56 | 50.82 | 57.96 | 66.11 | 75.40 | 86.00 | 98.09 |
| Personalized Medicine | 14.81 | 17.00 | 19.51 | 22.39 | 25.69 | 29.48 | 33.82 | 38.81 | 44.53 | 51.09 | 58.63 |
| Others | 4.94 | 5.77 | 6.74 | 7.86 | 9.18 | 10.70 | 12.47 | 14.53 | 16.93 | 19.71 | 22.94 |
Biomarkers Market Size By Disease 2024 to 2034 (USD )
| Disease | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 34.57 | 39.64 | 45.46 | 52.13 | 59.78 | 68.56 | 78.62 | 90.16 | 103.39 | 118.55 | 135.95 |
| Cardio | 11.52 | 13.17 | 15.04 | 17.19 | 19.64 | 22.44 | 25.64 | 29.30 | 33.48 | 38.26 | 43.72 |
| Neuro | 9.88 | 11.49 | 13.36 | 15.52 | 18.04 | 20.96 | 24.34 | 28.26 | 32.81 | 38.08 | 44.18 |
| Infectious | 11.52 | 13.00 | 14.66 | 16.53 | 18.63 | 21.00 | 23.67 | 26.67 | 30.05 | 33.84 | 38.11 |
| Autoimmune | 6.58 | 7.51 | 8.56 | 9.76 | 11.13 | 12.69 | 14.47 | 16.50 | 18.81 | 21.45 | 24.45 |
| Others | 8.23 | 9.44 | 10.82 | 12.41 | 14.23 | 16.32 | 18.71 | 21.45 | 24.60 | 28.21 | 32.34 |
Biomarkers Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 29.63 | 33.81 | 38.59 | 44.04 | 50.25 | 57.35 | 65.44 | 74.67 | 85.21 | 97.23 | 110.95 |
| Europe | 23.04 | 26.21 | 29.80 | 33.89 | 38.53 | 43.81 | 49.81 | 56.63 | 64.38 | 73.18 | 83.18 |
| Asia Pacific | 23.87 | 27.50 | 31.69 | 36.52 | 42.07 | 48.48 | 55.85 | 64.35 | 74.13 | 85.40 | 98.38 |
| Latin America | 3.29 | 3.78 | 4.35 | 5.00 | 5.74 | 6.60 | 7.59 | 8.72 | 10.02 | 11.51 | 13.23 |
| Middle East & Africa | 2.47 | 2.93 | 3.47 | 4.11 | 4.85 | 5.73 | 6.76 | 7.97 | 9.39 | 11.06 | 13.01 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
